Xiamen Kingdomway Stock Hits Day Low Amid Price Pressure at CNY 17.86

Xiamen Kingdomway Group Co., a large-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 7.6%. The stock reached an intraday low of CNY 17.86, reflecting broader market trends as the China Shanghai Composite index fell by 1.24% on the same day. Over the past week, Xiamen Kingdomway's performance has also been under pressure, declining by 4.59%, while its one-month performance shows a decrease of 4.24%. In contrast, the company has shown resilience over the past year, with a return of 16.5%, outpacing the China Shanghai Composite's 16.08% gain. Despite the recent downturn, Xiamen Kingdomway has reported positive results in its last three consecutive quarters, with a notable net profit growth of 59.97% in the first half of the year. The company boasts a return on equity of 11.11% and a competitive dividend yield of 2.14%. However, long-term growth remains a concern, as net sales have only increased at an annual rate of 0.25% over the last five years.